Clearmind Medicine Value At Risk
| CMND Stock | | | USD 0.72 0.05 7.46% |
The Value At Risk profile for Clearmind Medicine Common is based on historical price and volume observations. The dataset is based on observed market activity where data is available. Clearmind Medicine has a market cap of 1.4 M, current ratio of 0.03.
Trending Equities adds portfolio-level perspective. Clearmind Medicine Common can be evaluated within a portfolio framework for weight and risk impact. Position allocation is driven by the portfolio construction model in use. Broader economic conditions can influence Clearmind Medicine Common's company valuation — related indicators include
signals in inflation.
Clearmind Medicine Common has current Value At Risk of
-11.76. Value At Risk (or VAR) is a statistical technique used to measure the level of financial risk of investment instrument over a specific time frame. It is a widely used measure of the risk of loss on a specific investing instrument.
Value At Risk | = | ER[a] x N | + | (Z-SCORE x STD x SQRT (N)) |
| = | -11.76 | |
| ER[a] | = | Expected return on investing in Clearmind Medicine |
| STD | = | Standard Deviation of Clearmind Medicine |
| N | = | Number of points for the period |
| Z-SCORE | = | Number of standard deviations above or below the mean |
Value At Risk Peers Comparison
Value At Risk Relative To Other Indicators
Clearmind Medicine Common is rated
below average for value at risk relative to top peers. It is currently under evaluation for maximum drawdown relative to top peers .
Value At Risk is used by risk managers in order to measure and control the level of risk which the firm undertakes. The risk manager job is to ensure that risks are not taken beyond the level at which the firm can absorb the losses of a probable worst outcome. VAR can be defined as the loss level that will not be exceeded with a certain confidence level during a certain period of time.
Compare Clearmind Medicine to Peers
Other Technical Indicators